H3 Efficacy and tolerability of tasosartan, a novel angiotensin II antagonist: Results from a 10-week double-blind, placebo-controlled, dose-titration study | Zendy

AI Assistant Blog Pricing

H3 Efficacy and tolerability of tasosartan, a novel angiotensin II antagonist: Results from a 10-week double-blind, placebo-controlled, dose-titration study

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.